Grants closing in October 2026

For new independent group leaders (scientists; clinicians no longer eligible from May 2026) based at a UK university, medical school, hospital or research institution with a fully-funded salary. Applicant must be sole PI. Covers cancer-relevant basic, preclinical, imaging, radiotherapy, EPS, population, and early detection research. Equipment costs capped at £25k; relocation up to £1k.

Bilateral Weave collaboration between Switzerland (SNSF) and Croatia (HRZZ) under the SNSF project funding instrument. Swiss applicants apply as Lead Agency; projects must start on the same date in both countries and run for the same duration (max 48 months). Applicants may hold up to 3 simultaneous SNSF grants if one is a Weave/Lead Agency/International Co-Investigator or European Partnership project.

For established scientist group leaders at UK universities, medical schools, hospitals or research institutes. Applicants must hold a PhD or MD with extensive post-doctoral experience. Clinicians are no longer eligible from May 2026. Host institution must contribute 50% of salary. Sole PI only; full-time commitment expected (min 0.5 FTE for part-time). Covers basic, preclinical, imaging, radiotherapy, EPS, population and early detection cancer research.

Bilateral Switzerland–Luxembourg collaborative research projects under the Weave Lead Agency procedure. Limited to FNR's CORE multi-annual thematic programme on the Luxembourg side. Applicants may hold max 2 simultaneous SNSF project grants; one must be a Weave/Lead Agency/ICS project. Non-English proposals possible only in certain humanities/social sciences disciplines, requiring prior agency agreement.

Bilateral Switzerland–Poland collaborative research projects under the Weave framework. Swiss applicants must be based at Swiss institutions (SNSF project funding rules apply); Polish partners apply via NCN OPUS or Weave-UNISONO. Applicants may hold max 2 simultaneous SNSF project funding grants, one of which must be a Weave/Lead Agency project. Budget in EUR and PLN must be consistent across both submissions.

Swiss researchers can fund up to 50% of the SNSF budget for co-applicants in Denmark, Norway, Sweden, or the Netherlands (or 30% for UK subprojects in humanities/social sciences via ESRC/AHRC). No thematic overlap with ongoing SNSF projects allowed; applicants may not exceed two projects total, one of which must be a Weave/Lead Agency/International Co-Investigator Scheme project.

Bilateral Switzerland–Slovenia joint research projects under the Weave Lead Agency procedure. Swiss applicants must be hosted at a Swiss institution and apply under SNSF project funding rules. Applicants may hold max 2 simultaneous SNSF project grants; one must be a Weave/Lead Agency/International Co-Investigator project. Topics of concurrent grants must be clearly distinct. Project start date must be the same in both countries.

Bilateral Switzerland–Austria collaborative project funding under the Weave framework. Swiss applicants must be based at a Swiss institution (SNSF project funding). Max 2 simultaneous SNSF project grants; one must be a Weave/Lead Agency/ICS project. Non-English submissions possible in some humanities/social sciences disciplines with prior agency agreement. Duration identical in both countries, max 48 months.

Bilateral Switzerland–Czech Republic collaborative research projects under the Weave procedure. Swiss applicants submit to SNSF as Lead Agency; Czech partners submit to GACR. Project must start on the same date in both countries. Applicants may hold max two simultaneous SNSF project funding grants, one of which must be a Weave/Lead Agency project; topics must be clearly distinct.

Bilateral Switzerland–Germany project funding under the Weave/Lead Agency procedure. Swiss applicants must be hosted at a Swiss institution; proposals must be submitted in English. Max 2 simultaneous SNSF project grants allowed (one must be Weave/LA/ICS). Also open for Priority Programmes (max 36 months) and Research Units (max 48 months, up to 2 Swiss subprojects).

Bilateral Switzerland–Sweden Weave call under SNSF project funding. Swiss applicant applies to SNSF as Lead Agency; Swedish partner applies to Formas (environment, agricultural sciences, spatial planning). Max 2 simultaneous SNSF project grants; topics must be clearly distinct. Project start date must be the same in both countries.

Bilateral Weave/Lead Agency call between SNSF (Switzerland) and F.R.S.-FNRS (Wallonia-Brussels, Belgium). Belgian applicants must be based at one of six eligible universities (UCLouvain, ULB, ULiège, UMons, UNamur, USL-B). Projects must run for the same duration in both countries (max 48 months). Proposals in languages other than English (possible in some humanities/social sciences disciplines) require prior agreement with all agencies.

Bottom-up collaborative project funding for researchers from 2–3 European countries embedded in SNSF Project Funding. Lead Agency evaluates the joint proposal; aims to fund top 20% of submissions. Proposals must be submitted in English (exceptions for Austria and Luxembourg). Trilateral projects with France, Israel, São Paulo, South Africa, South Tyrol, or the US are not possible under Weave.

UK-led interdisciplinary research on wildfire resilience in the Wildland-Urban Interface (WUI), in collaboration with US (NSF) and/or Canadian (NSERC/SSHRC/CIHR) partners. Project lead must be UK-based; international co-leads required. Covers wildfire occurrence, impacts, and adaptation/mitigation/recovery interventions. Standard 20% FEC applies; no additional matched funding required.

For clinician scientists transitioning to research independence in cancer. Applicants must hold GMC registration, a higher degree (MD/PhD), CCT/consultant status, and be based at a UK university, medical school, hospital or research institute. Sole PI only; no fully-funded salary or prior substantial multi-year independent fellowship permitted. Fellows must remain clinically active (20–40% time).

For clinician scientists (MD/PhD) with GMC registration, a national training number, and some postdoctoral experience, hosted at a UK university, medical school, hospital or research institute. Applicants must remain clinically active during the fellowship. Covers cancer-relevant basic, preclinical, imaging, radiotherapy, EPS, population, and early detection research. Full-time basis; part-time possible with approval.

For scientists establishing an independent research group; must be based at a UK university, medical school, hospital or research institute. Applicant must not already hold a fully-funded salaried position or prior substantial multi-year PI fellowship. Sole lead applicant (PI) only; covers cancer-relevant basic, preclinical, imaging, radiotherapy, EPS, population, and early detection research.

Bilateral project funding under the Weave framework between SNSF and Sweden's Formas (environment, agricultural sciences, spatial planning). Swiss researchers must be hosted at Swiss institutions; max 2 simultaneous SNSF project grants, of which one must be Weave/Lead Agency/ICS. Topics of concurrent grants must be clearly distinct. Project start date must be the same in both countries.

Boehringer Ingelheim Fonds PhD Fellowship funds ambitious basic biomedical PhD projects. Europe-wide: EU citizens anywhere, or non-EU citizens whose PhD is at a European host. Experimental basic biomedical research only.

Bilateral project funding under the Weave procedure between SNSF (Switzerland) and GACR (Czech Republic). Applicants must be based at Swiss or Czech institutions. Max two simultaneous SNSF project grants allowed; one must be a Weave/Lead Agency project. Projects must start on the same date in both countries and run for the same duration (max 36 months).

Bilateral Swiss–US research collaboration under the Weave Lead Agency procedure. Swiss applicants must be hosted at Swiss institutions eligible for SNSF project funding; US partners at NSF-eligible institutions. Proposals must be submitted in English, declared as use-inspired, and address broader impact. Project must start on the same date and run for the same duration in both countries (max 48 months).

Weave bilateral project funding between Switzerland (SNSF) and Slovenia (ARIS). Swiss applicants apply to SNSF as Lead Agency (max 48 months); Slovenian-led projects go via ARIS (max 36 months). Applicants may hold max two simultaneous SNSF project grants, one of which must be a Weave/Lead Agency project. Topics of concurrent grants must be clearly distinct.

Collaborative bottom-up project funding for researchers from 2–3 European countries via the Lead Agency principle. Proposals must be submitted in English (exceptions for Austria and Luxembourg). Each applicant must meet eligibility criteria of their national funder. Swiss sub-project budget submitted via SNSF portal; aims to fund top 20% of proposals in the relevant evaluation round. Trilateral projects with France, Israel, São Paulo, South Africa, South Tyrol, or the US are not possible.

Joint bilateral research proposals between Switzerland and a partner country (6 countries/regions with Lead Agency agreements). Swiss subproject governed by SNSF project-funding rules; proposals must be in English. Max 2 simultaneous project-funding grants per researcher; max 20% of Swiss budget for additional project partners. Evaluation may take longer than regular SNSF projects due to coordination.

Bilateral project funding under the Weave framework between SNSF and Sweden's Formas (environment, agricultural sciences, spatial planning). Swiss applicant must be hosted at a Swiss institution; max 2 simultaneous SNSF project grants, of which one must be Weave/Lead Agency/ICS. Topics of concurrent grants must be clearly distinct. Project start date must be the same in both countries.

Boehringer Ingelheim Fonds MD Fellowship funds medical students (primarily enrolled in Germany) for an experimental basic-biomedical research project in a leading lab away from their home institution.

For early-career oncology researchers within 5 years of PhD (extensions possible for clinical training or parental leave). Project leader must hold a PhD and be employed ≥0.5 FTE throughout. Covers all research phases from basic to implementation. Applicants must be affiliated with a KWF-registered institute (registration required ≥6 weeks before deadline). Proposals must be submitted exclusively to this call.

Open cancer research call covering Creation of Modality, Preclinical, Clinical, or Implementation research phases. Proposals must include a development plan with steps, stakeholders, feasibility, and risks. Projects falling within scope of specific thematic calls (biomarker validation/implementation, PIPELINE, INTER-LOCAL, pancreatic screening) are excluded. Dutch summary and patient participation section required; PACO review weighted 30%.

Open to consortia addressing 'wicked problems' based on NWA-route themes and cluster questions, spanning the full knowledge chain (fundamental to practice-oriented research) with societal partners including citizens. Main applicant must have participated in both collaborative workshops for the relevant theme. Proposals assessed on problem definition, impact, consortium quality, and research quality.

PRIMA Call 2026 Section 1 — joint transnational call by the PRIMA European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating funders.

Pilot Weave call between the Research Council of Norway and Formas (Sweden). Norwegian researchers at approved Norwegian research institutions may participate in project applications with a Swedish lead applicant via Formas' open 'Explore' call. Proposals must be submitted in collaboration with Swedish colleagues. Scope: environment, land-based industries, and society. (Innovative research in environment and society)

Funds research into the mechanisms of interaction between heat and hypertension. Open to Research Leaders (Established/Prof.) based in Denmark. Focus areas: Endocrinology and Metabolism, Bioscience and Basic Biomedicine, Clinical and Translational Medicine.

Open to Research Leaders (Established/Prof.) internationally. Focus on industrial and environmental biotechnology — specifically unravelling electron transfer mechanisms in hybrid bio-electrocatalysis. Applications submitted via the Norma portal.

Funds leading researchers forming a consortium to address major scientific challenges in harnessing novel Earth-abundant materials for sustainable technologies. Open to international applicants; career stage: established research leaders/professors. Focus on natural sciences within the Novo Nordisk Foundation Strategy.

Open to Research Leaders (Established/Prof.) internationally. Focus on natural sciences — harnessing novel Earth-abundant materials for sustainable technologies. Applications submitted via the NORMA portal.

Supports early-career researchers (postdoctoral, lecturers, junior fellows) who have not previously led a research team or held a substantial grant, enabling transition to independence through an experimental medicine project in humans. Salary capped at 50% of contracted working time; applicant must be sole intellectual leader. Typical duration three years.

Directly funded by the European Union and fully managed by the PRIMA Foundation. Supports transnational research and innovation projects among Mediterranean countries. Focuses on water management, agricultural systems, and the agri-food chain (water-energy-food-ecosystems nexus). Consortium of partners from Mediterranean/EU countries required.

Funds next-generation AMR diagnostics for lower respiratory tract infections. Open to established research leaders / professors internationally. Two-stage process with results announced December 2026 (Stage 1) and June 2027 (Stage 2).

Funds academically-led experimental medicine projects conducted in humans, investigating causes, progression and treatment of human disease. UK research organisations eligible as lead; international co-leads permitted (costs capped at 30% for high-income countries). Includes a New Investigator Award track for early-career researchers transitioning to independence (salary capped at 50% FTE). Clinical studies assessing safety/efficacy of treatments are ineligible.

Pilot call under the European Weave collaboration between the Research Council of Norway and Formas (Sweden). Norwegian researchers at approved Norwegian research institutions can participate in project applications with a Swedish lead applicant via Formas' open 'Explore' call. Focus: environment, land-based industries, and society.

IHI Call 13 — joint transnational call by the Innovative Health Initiative European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating funders.

European Partnership co-funded by the European Commission under Horizon Europe (CETP), pooling regional and national organisations to address clean energy transition challenges. Independent investigator-led. Consortium required per Horizon Europe rules.

Scholar stipends and international stays (udlandsophold) for cancer researchers. Early-career focused. A further round is expected in May 2027. Proposals likely in Danish.

Supports Danish universities or other research institutions in recruiting top researchers of any nationality. Aims to enhance researcher mobility across borders, among Danish universities, and from industry to university. Host institution must be in Denmark.

Supports Danish universities and research institutions in recruiting top researchers of any nationality. Aims to enhance researcher mobility across borders, among Danish universities, and from industry to university. Host institution must be in Denmark.

CETP Joint Call 2026 — joint transnational call by the CETP European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating funders.

Supports Danish universities/research institutions recruiting top researchers of any nationality. Grants of up to DKK 5M (assistant professor/tenure track), DKK 8M (associate professor), or DKK 10M (full/clinical professor) to fund establishment of an independent research group. Host institution must be in Denmark; enhances researcher mobility from abroad or industry to academia.

International technical mobility grant (MOBITECH) co-funded by Fondation ARC and the Société Française du Cancer (SFC). Supports technical/scientific international mobility in cancer research. Proposals likely in French.

Achieving open strategic autonomy in digital and emerging en — joint transnational call by the Made in Europe European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for

Open to researchers of any nationality, 0–10 years post-PhD (extensions possible for parental leave, illness, etc.), proposing frontier research in any field. Host institution must be a public or private research organisation in an EU Member State or Horizon Europe associated country. Single PI applies; no consortium required.

Two-year travel grants for UK-based observers with travel costs exceeding £7,500/year, covering travel and subsistence for competitively awarded science observation time at PATT-approved astronomy facilities. Applicants must be project lead, co-lead, nominated representative, or academic/research staff at the project lead's institution. Funds 100% FEC; does not cover postdoctoral salaries, equipment, or commissioning work.

For a PhD-holding clinician/medical researcher who continues clinical work alongside research (30–50% of working time for research). Requires an active employment contract throughout the grant period. Covers personal salary costs (reported by employer) plus up to €350,000 in research costs. Grant paid to employer institution.

Seeks a sector-led partnership to develop a CI-specific USIT-style commercialisation guide for UK universities. Lead organisation must be a UK research organisation registered on the UKRI Funding Service. Partners must include organisations with proven CI commercialisation experience and investors. Projects must start by 1 April 2027. In collaboration with Research England.

For a docent or equivalent independent medical researcher without a research post during the grant period. Covers personal salary costs plus partial research costs. Grant paid to the employer institution, with whom the researcher signs an employment contract. Proposals in Finnish/Swedish.

Proof of Concept in Materials Science from the Knut and Alice Wallenberg Foundation, a major Swedish private research funder. The applicant must hold a long-term association with a Swedish higher-education institution (≥70% of working time in Sweden).

For postdoctoral medical researchers or those with equivalent scientific competence who hold an active clinical post for the grant duration. Researcher must dedicate 30–50% of working hours to research. Covers researcher's salary (employer-calculated) plus up to €350,000 in additional research costs. Grant paid to employer.

For adjunct professors (docents) or independent medical researchers with equivalent qualifications who have no research post or employment contract for the applied period. Grant covers researcher's salary and some research costs. Grant paid to employer; researcher must have no other post during the grant period.

Funds nationwide implementation of clinically validated oncology biomarkers (TRL 7–9) in the Netherlands. Requires a multidisciplinary consortium of ≥4 parties, an HTA specialist in the team, a KWF-approved steering committee, and structural embedding of the patient perspective. PhD candidates are strongly discouraged. Public/private collaborations encouraged if co-funding is in place.

6+ (SSH) call for at least one new NCCR in social sciences and humanities. Director must have SSH background; majority of team of directors and PIs must be active in SSH. Proposals must be in English. Director must hold a permanent position at a recognised Swiss home institution. Home institutions must match SNSF funding. Decision expected late 2027; selected NCCR(s) start first half of 2028.

Clinical validation of known oncology biomarkers (TRL 5/6) for use in daily clinical practice. Requires multidisciplinary consortium of ≥4 parties, mandatory (early) HTA component, patient involvement, and robust statistical expertise. AI-component projects must engage AI4Health consortium. Discovery-phase (TRL 1–4) and side-effect biomarkers are out of scope.

Joint NWO–FAPESP call for interdisciplinary research on replacing fossil raw materials with circular biomass-derived materials in the chemical industry. Dutch main applicant must be at a research organisation in the Netherlands; São Paulo applicant must confirm eligibility with FAPESP. Mandatory 30% co-funding from a private company. Research must cover multiple perspectives (chemical engineering, economics, sustainability, social, legal).

Open to experienced researchers based at Swiss higher education/research institutions (ETH domain, accredited universities, UAS, UTE, or research facilities of national importance). NCCR director must hold a permanent position, have an SSH background, and commit for at least 4 years. Majority of directors and PIs must be SSH-active. Home institutions must co-fund matching SNSF contribution. Proposals must be submitted in English via mySNF.

FNR LuxAid BRIDGES — for Established Researchers — International collaboration, Thematically Focussed Project Funding. Hosted at a Luxembourg research institution.

Supports Danish primary and secondary school teachers (public or private) in STEM/natural science subjects to attend short professional development courses. Individual applications only (one per teacher per year), with prior approval from school principal. Proposals must be in Danish. Grant covers course fee, substitute cover for up to 5 course days, and 3 development days.

Supports Danish primary and secondary school teachers (public or private) in STEM/natural science subjects to attend short continuing professional development courses in school year 2027/28. Individual applications only (one per teacher per year), with prior approval from school principal. Covers course fee, up to 5 course days (substitute cover), and 3 development days. Proposals must be in Danish.

Trans-Atlantic Platform (TAP) fifth international call for collaborative SSH research on how societies envision and respond to uncertain futures. Proposals must be submitted via the DFG elan portal. Encourages involvement of early career researchers. Transnational teams required; national addenda apply per participating country.

EIC call (HORIZON-EIC-2026-STEP-DEFENCE-01): HORIZON EIC Equity Only

EIC call (HORIZON-EIC-2026-PATHFINDERCHALLENGES-01): HORIZON EIC Grants

EIC call (HORIZON-EIC-2026-PATHFINDERCHALLENGES-01): HORIZON EIC Grants

EIC call (HORIZON-EIC-2026-PATHFINDERCHALLENGES-01): HORIZON EIC Grants

ERDERA Clinical Trial Call 2026 (pre-announcement) — joint transnational call by the ERDERA European Partnership, listed on the ERA-LEARN joint-call calendar. Funded by national/regional agencies in participating countries; requires a transnational consortium. See the call page for participating fun

Open only to approved Norwegian research organisations invited to apply because they will host an HFSP Postdoctoral Fellowship recipient awarded in March 2026. The postdoctoral candidate must be the project manager. Supplements HFSP funding to bring the fellow's salary to institutional norms. Proposals may be submitted in Norwegian or English; Norwegian text is legally binding.